Enjaymo (sutimlimab) / Sanofi  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Enjaymo (sutimlimab) / Sanofi
CADENCE, NCT05791708: Cold Agglutinin Disease Real World Evidence Registry

Recruiting
N/A
400
Europe, Japan, US
Sutimlimab
Sanofi
Cold Agglutinin Disease (CAD), Cold Agglutinin Syndrome (CAS)
11/28
11/28

Download Options